UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 8, 2023
October 30 2023 - 4:45PM
Emergent BioSolutions Inc. (NYSE: EBS) has rescheduled its
conference call to Wednesday, November 8, at 5:00 pm eastern time
to discuss the financial results for the third quarter of 2023,
recent business developments, and financial outlook for full year
2023. The call will no longer take place on November 2, 2023.
Conference Call InformationParticipants can
access the conference call live via webcast from the Investors page
of Emergent’s website. To participate via telephone, please
register in advance at this link. Upon registration, all telephone
participants will receive a confirmation email detailing how to
join the conference call, including the dial-in number along with a
unique passcode and registrant ID that can be used to access the
call.
A replay of the call can be accessed from the Investors page of
Emergent’s website.
About Emergent BioSolutionsAt Emergent, our
mission is to protect and enhance life. For 25 years, we’ve been at
work defending people from things we hope will never happen—so we
are prepared just in case they ever do. We provide solutions for
complex and urgent public health threats through a portfolio of
vaccines and therapeutics that we develop and manufacture for
governments and consumers. We also offer a range of integrated
contract development and manufacturing services for pharmaceutical
and biotechnology customers. To learn more about how we plan to
protect or enhance 1 billion lives by 2030, visit our website and
follow us on LinkedIn, Twitter, and Instagram.
Investor Contact:Richard S.
LindahlExecutive Vice President, CFOlindahlr@ebsi.com
Media Contact:Assal HellmerVice
President, Communicationsmediarelations@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2024 to May 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From May 2023 to May 2024